Cargando…

Synthesis of RP 48497, an Impurity of Eszopiclone

RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Yu, Zhang, Lei, Du, Gui-Jie, Ren, Jian, Cheng, Mao-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245065/
https://www.ncbi.nlm.nih.gov/pubmed/18794786
http://dx.doi.org/10.3390/molecules13081817
_version_ 1783372168881504256
author Sha, Yu
Zhang, Lei
Du, Gui-Jie
Ren, Jian
Cheng, Mao-Sheng
author_facet Sha, Yu
Zhang, Lei
Du, Gui-Jie
Ren, Jian
Cheng, Mao-Sheng
author_sort Sha, Yu
collection PubMed
description RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its (1)H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone.
format Online
Article
Text
id pubmed-6245065
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62450652018-11-26 Synthesis of RP 48497, an Impurity of Eszopiclone Sha, Yu Zhang, Lei Du, Gui-Jie Ren, Jian Cheng, Mao-Sheng Molecules Communication RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its (1)H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone. MDPI 2008-08-22 /pmc/articles/PMC6245065/ /pubmed/18794786 http://dx.doi.org/10.3390/molecules13081817 Text en © 2008 by the authors. Licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Communication
Sha, Yu
Zhang, Lei
Du, Gui-Jie
Ren, Jian
Cheng, Mao-Sheng
Synthesis of RP 48497, an Impurity of Eszopiclone
title Synthesis of RP 48497, an Impurity of Eszopiclone
title_full Synthesis of RP 48497, an Impurity of Eszopiclone
title_fullStr Synthesis of RP 48497, an Impurity of Eszopiclone
title_full_unstemmed Synthesis of RP 48497, an Impurity of Eszopiclone
title_short Synthesis of RP 48497, an Impurity of Eszopiclone
title_sort synthesis of rp 48497, an impurity of eszopiclone
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245065/
https://www.ncbi.nlm.nih.gov/pubmed/18794786
http://dx.doi.org/10.3390/molecules13081817
work_keys_str_mv AT shayu synthesisofrp48497animpurityofeszopiclone
AT zhanglei synthesisofrp48497animpurityofeszopiclone
AT duguijie synthesisofrp48497animpurityofeszopiclone
AT renjian synthesisofrp48497animpurityofeszopiclone
AT chengmaosheng synthesisofrp48497animpurityofeszopiclone